Article
Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Transfusion - 1 Sept 2004
Denomme G A, Ryan G, Seaward P G R, Kelly E N, Fernandes B J
Abstract excerpt
BACKGROUND: Clinically significant antibodies to high-incident antigens present a challenge in hemolytic disease of the newborn. Antigen-negative blood may be difficult to obtain for intrauterine transfusion (IUT). In these instances, maternal blood is de facto compatible regardless of an ABO mismatch. CASE REPORT: A group B/D-- woman with a history of hemolytic disease of the newborn due to anti-Rh17 (titer 256)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.